Every five years, the U.S. government releases an updated set of recommendations on healthy eating. This document, called the ...
According to the World Health Organization, each year cervical cancer impacts approximately 600,000 women throughout the ...
Generalized anxiety disorder is a highly prevalent mental disorder. Previous data indicate that more than 18 million Brazilians suffer from this condition. Traditionally, generalized anxiety disorder ...
To align with its mission to reduce the global burden of raised blood pressure (BP), the International Society of Hypertension (ISH) has developed worldwide practice guidelines for the management of ...
Advancements in HIV/AIDS research, drug development, and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check ...
Dec 15 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling drug Biktarvy in a late-stage ...
Gilead Sciences said its in-development HIV treatment met the primary endpoint of a recent late-stage clinical trial. The biopharmaceutical company said Monday that the treatment, a once-daily single ...
– Positive Phase 3 Results from Both ARTISTRY-2 and ARTISTRY-1 Trials will Form the Basis of Regulatory Submissions – FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today ...
Largely federally funded study by Johns Hopkins Medicine-led team suggests finding may be an early step toward a potential HIV cure Paper in @jclinicalinvest (bit.ly/497z6jo) by @HopkinsMedicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback